Comment by
Moonshiner592 on Mar 06, 2021 9:34pm
Care to read some more? Go to Kalyteran.co
Comment by
Moonshiner592 on Mar 07, 2021 7:37am
FYI - Their principal product (R107) being developed to fight COVID is not only resistant to all its mutations... but it also can fight any other RNA encoded virus .. such as the common cold and flu .. Hepatitis C and E .. polio .. Ebola .. measles With their worldwide patent for R107 ... they can get massive!
Comment by
beenthere on Mar 07, 2021 3:23pm
I don't like any company that has more than Half A Billion shares out! That'a A Lot of shares! lol 546 075 000 shares outstanding!
Comment by
Moonshiner592 on Mar 07, 2021 4:25pm
Don't let those numbers fool you... Claritas has undergone a major restructuring... and has lots of upside to it .. especially with a worldwide patent...
Comment by
George141 on Mar 07, 2021 5:14pm
..I agree 100%...they do have a large part of the population vaccinated. This should give them an edge...well at least a good chance. Rome was not built in one day either....maintain
Comment by
bligicka on Mar 07, 2021 3:12pm
Nothing to be happy about ......
Comment by
Moonshiner592 on Mar 07, 2021 4:27pm
If you're referring to the recent happenings with Vaxil ... then ... yes - I for one wouldn't be to pleased